Cargando…

Genetic Variation Putatively Associated with Mycobacterium tuberculosis Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis

Perchlozone ([PCZ] 4-thioureido-iminomethylpyridinium perchlorate) is a new thiosemicarbazone approved for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Russia and some other countries. The ethA and hadABC mutations may confer PCZ resistance. At the same time, ethA mutations are know...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokrousov, Igor, Vyazovaya, Anna, Akhmedova, Gulnora, Solovieva, Natalia, Turkin, Eugeni, Zhuravlev, Viacheslav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601826/
https://www.ncbi.nlm.nih.gov/pubmed/33022959
http://dx.doi.org/10.3390/antibiotics9100669
_version_ 1783603524870864896
author Mokrousov, Igor
Vyazovaya, Anna
Akhmedova, Gulnora
Solovieva, Natalia
Turkin, Eugeni
Zhuravlev, Viacheslav
author_facet Mokrousov, Igor
Vyazovaya, Anna
Akhmedova, Gulnora
Solovieva, Natalia
Turkin, Eugeni
Zhuravlev, Viacheslav
author_sort Mokrousov, Igor
collection PubMed
description Perchlozone ([PCZ] 4-thioureido-iminomethylpyridinium perchlorate) is a new thiosemicarbazone approved for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Russia and some other countries. The ethA and hadABC mutations may confer PCZ resistance. At the same time, ethA mutations are known to mediate resistance to ethionamide (ETH) and prothionamide (PTH). We aimed to study the genetic variation underlying Mycobacterium tuberculosis resistance to PCZ through whole genome sequencing (WGS) of consecutive isolates recovered during long-term treatment. This prospective study included patients admitted in 2018–2019 to the regional tuberculosis dispensary, Kaliningrad, Russia, whose treatment regimen included PCZ. Multiple M. tuberculosis isolates were recovered during PCZ treatment, and the bacterial DNA was subjected to WGS followed by bioinformatics analysis. We identified mutations in the genes putatively associated with PCZ resistance, ethA, and hadA. The most frequent one was a frameshift ethA 106 GA > G (seven of nine patients) and most of the other mutations were also likely present before PCZ treatment. In one patient, a frameshift mutation ethA 702 CT > C emerged after six months of PCZ treatment. A frequent presence of cross-resistance mutations to PCZ and ETH/PTH should be taken into consideration when PCZ is included in the treatment regimen of MDR-TB patients.
format Online
Article
Text
id pubmed-7601826
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76018262020-11-01 Genetic Variation Putatively Associated with Mycobacterium tuberculosis Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis Mokrousov, Igor Vyazovaya, Anna Akhmedova, Gulnora Solovieva, Natalia Turkin, Eugeni Zhuravlev, Viacheslav Antibiotics (Basel) Article Perchlozone ([PCZ] 4-thioureido-iminomethylpyridinium perchlorate) is a new thiosemicarbazone approved for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Russia and some other countries. The ethA and hadABC mutations may confer PCZ resistance. At the same time, ethA mutations are known to mediate resistance to ethionamide (ETH) and prothionamide (PTH). We aimed to study the genetic variation underlying Mycobacterium tuberculosis resistance to PCZ through whole genome sequencing (WGS) of consecutive isolates recovered during long-term treatment. This prospective study included patients admitted in 2018–2019 to the regional tuberculosis dispensary, Kaliningrad, Russia, whose treatment regimen included PCZ. Multiple M. tuberculosis isolates were recovered during PCZ treatment, and the bacterial DNA was subjected to WGS followed by bioinformatics analysis. We identified mutations in the genes putatively associated with PCZ resistance, ethA, and hadA. The most frequent one was a frameshift ethA 106 GA > G (seven of nine patients) and most of the other mutations were also likely present before PCZ treatment. In one patient, a frameshift mutation ethA 702 CT > C emerged after six months of PCZ treatment. A frequent presence of cross-resistance mutations to PCZ and ETH/PTH should be taken into consideration when PCZ is included in the treatment regimen of MDR-TB patients. MDPI 2020-10-03 /pmc/articles/PMC7601826/ /pubmed/33022959 http://dx.doi.org/10.3390/antibiotics9100669 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mokrousov, Igor
Vyazovaya, Anna
Akhmedova, Gulnora
Solovieva, Natalia
Turkin, Eugeni
Zhuravlev, Viacheslav
Genetic Variation Putatively Associated with Mycobacterium tuberculosis Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
title Genetic Variation Putatively Associated with Mycobacterium tuberculosis Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
title_full Genetic Variation Putatively Associated with Mycobacterium tuberculosis Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
title_fullStr Genetic Variation Putatively Associated with Mycobacterium tuberculosis Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
title_full_unstemmed Genetic Variation Putatively Associated with Mycobacterium tuberculosis Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
title_short Genetic Variation Putatively Associated with Mycobacterium tuberculosis Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
title_sort genetic variation putatively associated with mycobacterium tuberculosis resistance to perchlozone, a new thiosemicarbazone: clues from whole genome sequencing and implications for treatment of multidrug-resistant tuberculosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601826/
https://www.ncbi.nlm.nih.gov/pubmed/33022959
http://dx.doi.org/10.3390/antibiotics9100669
work_keys_str_mv AT mokrousovigor geneticvariationputativelyassociatedwithmycobacteriumtuberculosisresistancetoperchlozoneanewthiosemicarbazonecluesfromwholegenomesequencingandimplicationsfortreatmentofmultidrugresistanttuberculosis
AT vyazovayaanna geneticvariationputativelyassociatedwithmycobacteriumtuberculosisresistancetoperchlozoneanewthiosemicarbazonecluesfromwholegenomesequencingandimplicationsfortreatmentofmultidrugresistanttuberculosis
AT akhmedovagulnora geneticvariationputativelyassociatedwithmycobacteriumtuberculosisresistancetoperchlozoneanewthiosemicarbazonecluesfromwholegenomesequencingandimplicationsfortreatmentofmultidrugresistanttuberculosis
AT solovievanatalia geneticvariationputativelyassociatedwithmycobacteriumtuberculosisresistancetoperchlozoneanewthiosemicarbazonecluesfromwholegenomesequencingandimplicationsfortreatmentofmultidrugresistanttuberculosis
AT turkineugeni geneticvariationputativelyassociatedwithmycobacteriumtuberculosisresistancetoperchlozoneanewthiosemicarbazonecluesfromwholegenomesequencingandimplicationsfortreatmentofmultidrugresistanttuberculosis
AT zhuravlevviacheslav geneticvariationputativelyassociatedwithmycobacteriumtuberculosisresistancetoperchlozoneanewthiosemicarbazonecluesfromwholegenomesequencingandimplicationsfortreatmentofmultidrugresistanttuberculosis